¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"IVC"¿¡ ´ëÇÑ ¿µ¿µ ÀÇÇлçÀü ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
IVC <abbreviation> Inferior vena cava.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
azygos continuation of interrupted ivc <radiology> IVC interrupted, hepatic portion absent, joins azygos or hemiazygos, hepatic veins empty directly into RA, associated with polysplenia
(12 Dec 1998)
bird's nest ivc filter <radiology> Introduced 1982; Cook Inc., Bloomington, IN advantages, low profile: 14.5 Fr introducer sheath, low recurrent PE rates (1.1 - 2.7% by clinical history), low IVC thrombosis rates (2.9 - 5.0% by clinical history), placement in large diameter IVCs (not greater than40mm), free-form configuration does not require centreing in IVC disadvantages: stainless steel: ferromagnetic = magnetic susceptibility artifact, more operator dependent, difficult to place in short IVCs (need about 7cm for proper placement), prolapse of filter wires (? clinical significance) see also: indications
(12 Dec 1998)
vena-tech ivc filter <radiology> Introduced as LGM (L.G. Medical, France), 1985; FDA aprroval 1991: Vena-Tech, Evanston, IL, 6-leg conical design with 6 stabilizing side bars, biocompatible metal known as Phynox (cobalt,chromium,iron,nickel,moly) Efficacy, recurrent PE: 2-6%, IVC occlusion: 8-24%, migration: 0-12% Advantages, ease of placement, excellent clot trapping efficiency, low profile, lacks ferromagnetic activity: minimal MRI artifacts Disadvantages, incomplete opening (6-19%): decreases clot-trapping efficiency, increased incidence from IJ approach, decreased with rapid deployment, increased IVC thrombosis rates: 8% initial reports; 22-24% on subsequent reports by ultrasound/MRI: 2-19% clinically symptomatic
(12 Dec 1998)
simon nitinol ivc filter <radiology> Introduced 1990; Nitinol Medical Technologies, Woburn, MA. BARD, thermal memory alloy:titanium and nickel;, straightened form at cool temperatures (4-10C), reforms into predetermined filter shape at body temperatures efficacy, recurrent PE: 0 - 4.8%, IVC thrombosis: 7 - 11% (by clinical symptoms), access site thrombosis: 2 - 10% advantages, narrow introducer sheath (9 Fr), largest choice of access: brachial or left CFV approach without difficulty, only mild MRI artifacts disadvantages, IVC thrombosis: symptomatic occlusion rates higher than reported wtih Greenfield or bird's nest filters, caval penetration: 1 - 33%, caudal drop: exact filter location difficult to predict
(12 Dec 1998)
titanium greenfield ivc filter <radiology> Advantages: low profile: 14.3 Fr introducer sheath, percutaneous placement, lack of ferromagnetic properties, low recurrent PE rate (3-5%), low IVC thrombosis rate (1-9%), successful placement (97%) disadvantages: maximum caval diameter = 28mm, tilting/leg assymetry, difficult placement from left femoral approach see also: indications
(12 Dec 1998)
ÅëÇÕ°Ë»ö ¿Ï·á